ECO 2024 — Dr Riccardo Panella (Aalborg University, DK) joins us to discuss a ncRNA-based approach in treating obesity. This new combinatory treatment (Resalis) aims to increase GLP1-RA efficacy by targeting non-coding RNA.

Questions
1. What is the background of this combinatory approach?
2. What data did you present at ERA 24?
3. What are the challenges and opportunities in approaching combinatory treatment?
4. Where are the knowledge gaps?
5. What are the next steps?

Support: This is an independent content produced by Radcliffe Cardiology.

Videographer: Oliver Miles
Interviewer: Jordan Rance
Editor: Mirjam Boros